Aclarion vs Profusa
ACON and PFSA side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACON and PFSA compare
Aclarion is the larger company, worth 65 times as much as Profusa ($4.7M against $72.8K).
Aclarion scores higher on the StockData Score (8 against 0 for Profusa), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACON | PFSA |
|---|---|---|
| Size and price | ||
| Market cap | $4.7M | $72.8K |
| Share price | $1.63 | $0.550 |
| Change, 1 year | −77.5% | −100.0% |
| Beta (5Y) | 0.77 | 0.46 |
| Employees | 11 | – |
| StockData Score | ||
| Total score | 8 (better) | 0 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 47.7× | – |
| P/B | 0.3× | – |
| Growth | ||
| Revenue growth (TTM) | 46.0% | – |
| Profitability | ||
| Gross margin | 29.1% | – |
| Operating margin | −10789% | – |
| Net margin | −10260% | – |
| Return on equity | −74.1% | – |
| Return on invested capital | −959% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −136.6× |
| Current ratio | 14.17 (better) | 0.03 |
| Altman Z-score | −4.34 (better) | −364.70 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | −33.4% | – |
| Shareholder yield | −33.4% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 9.0% | 25.3% |
| Held by insiders | 16.4% | – |
| Insider net buying, 12 months | $177K (better) | −$116K |
Go deeper
- ACON stock overview
- ACON income statement
- ACON valuation and score
- PFSA stock overview
- PFSA income statement
- PFSA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.